Antibody with engineered peptide targets bone metastasis
A moderate amount of a peptide-enhanced cancer drug goes a long way in treating breast cancers that metastasize to the bone.
Materials provided by Rice University. Original written by Mike Williams. Note: Content may be edited for style and length.
Source link aaaaa